The A-List: 2009's Trend-Shaping Series A Financings
This article was originally published in Start Up
Executive Summary
New company creation slipped significantly in 2009 as venture capitalists conserved capital and supported existing portfolio companies. In biopharmaceuticals, corporate venture got in at the ground floor while device start-ups continued to see stronger support from smaller, regional investors than traditional VCs.